TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05227573 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04880317 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04817540 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04817540 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT05305183 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05572515 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06668831 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT06672250 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT06667076 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06667076 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06512402 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05770349 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05770349 — Safety Biomarker (SAF): Cytochrome c
Study NCT06147973 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05244980 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06023576 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05037331 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06346912 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06346912 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT05065021 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT06080750 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06080750 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06510335 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05027269 — Predictive Biomarker (PRD): DMPK mRNA
Genes: DMPK; DM1PK; MDPK
Study NCT05092061 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05561075 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT05561075 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04789057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04789057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04347655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04885738 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06513598 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06109922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06054958 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06619483 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06150378 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04712383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05333718 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05744297 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04798079 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT06625242 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT06626256 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05124756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05935709 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT05975021 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05530512 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05872659 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05503030 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05152914 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT04964284 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05164965 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04767308 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT04132232 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT06714656 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06364748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06721507 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06721507 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06721507 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06721507 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06721507 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06395519 — Predictive Biomarker (PRD): PARG mRNA
Genes: PARG
Study NCT06378710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05164523 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05164523 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05164523 — Safety Biomarker (SAF): BDNF
Study NCT04881526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06075615 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06370247 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05675605 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05643326 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06217185 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05750667 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT05965570 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06135194 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05998928 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05998928 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT05503121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05503121 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05503121 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT05901181 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04766918 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05227846 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05370456 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05370456 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06760273 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05666115 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06320951 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT06320951 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT04946227 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04978753 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06764875 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06765057 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06764563 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05263882 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04939974 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT06767449 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06027983 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04868240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03133988 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05990621 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05074173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05925218 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06168227 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05504720 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05125887 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04877223 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT04267237 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05310565 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03663153 — Predictive Biomarker (PRD): SEMA4C mRNA
Genes: SEMA4C; KIAA1739; SEMAI; UNQ5855/PRO34487
Study NCT05578625 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05170568 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05050422 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05971901 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT05971901 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06242483 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05338086 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05461729 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06060080 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05241444 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05241444 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT05491642 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05825612 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT05825612 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05839626 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05682573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05682573 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05682573 — Safety Biomarker (SAF): Th2 cell
Study NCT06533384 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06172790 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05981014 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05253807 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT05909527 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06503237 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06503237 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT06388369 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05418361 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05418361 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04865081 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05960955 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT04962399 — Predictive Biomarker (PRD): PNOC mRNA
Genes: PNOC; OFQ
Study NCT05366205 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06151184 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT06152068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06152068 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT06152068 — Safety Biomarker (SAF): Interleukin 1
Study NCT04924803 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05096169 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04842487 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT04842487 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT05270161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGG mRNA
Genes: FGG; PRO2061
Study NCT05270161 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05065463 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05475873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06512324 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06671288 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05618080 — Predictive Biomarker (PRD): CAPN3 mRNA
Genes: CAPN3; CANP3; CANPL3; NCL1
Study NCT06433427 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05799690 — Predictive Biomarker (PRD): KCNK3 mRNA
Genes: KCNK3; TASK; TASK1
Study NCT05799690 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT05799690 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05799690 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05799690 — Safety Biomarker (SAF): BDNF
Study NCT05863429 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03985501 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05744986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04760132 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05798962 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05873777 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05873777 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT04896775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06440902 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06440902 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06440902 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT06440902 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06438367 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05093387 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06336408 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05153408 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05175950 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05893082 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT06338449 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06544018 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study NCT06544018 — Predictive Biomarker (PRD): NPAS2 mRNA
Genes: NPAS2; BHLHE9; MOP4; PASD4
Study NCT06544018 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06468163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06468163 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00002042 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT05521113 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05455762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04735575 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT06209697 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06209697 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04870177 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05790304 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06071286 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06071286 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04698265 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04497610 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05798039 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04528771 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05263947 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06613152 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06253780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06041581 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06041581 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04746872 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06511427 — Predictive Biomarker (PRD): SHB mRNA
Genes: SHB
Study NCT05409755 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06408194 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04983901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05837143 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT06272214 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06272214 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05497700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05064839 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05941091 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05508568 — Predictive Biomarker (PRD): MCM5 mRNA
Genes: MCM5; CDC46
Study NCT05373030 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05958277 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05208307 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05765981 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT04535557 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05067660 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05190575 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT04856475 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06346808 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06652100 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05346562 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05661721 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04710368 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT04710368 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT05631899 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05631899 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06333483 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04891731 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT04891731 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04891731 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06201273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04249453 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06133010 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05262959 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04319783 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05950139 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05585853 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06304441 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06304441 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05262855 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04707196 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04707196 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study NCT04707196 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04707196 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04707196 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04707196 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05016544 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06229314 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05249777 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06264544 — Predictive Biomarker (PRD): SELENOP mRNA
Genes: SELENOP; SELP; SEPP1
Study NCT05341388 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05341388 — Safety Biomarker (SAF): BDNF
Study NCT03648645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06077981 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04698408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04810572 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT05561179 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04573777 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05212779 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06513260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05012787 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05060250 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05819684 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05868720 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05772299 — Surrogate Endpoint (SUR): Probing pocket depth